« A rating scale for emotional blunting, The American Journal of Psychiatry, vol.135, issue.2, pp.226-229, 1978. ,
, « Les Thérapies Comportementales et Cognitives | AFTCC », 2015.
« Treatment of Negative Symptoms: Where Do We Stand, and Where Do We Go?, Schizophrenia Research, vol.186, pp.55-62, 2017. ,
The Integrative Power of Cognitive Therapy, 1997. ,
, « Negative Symptoms in Schizophrenia. Definition and Reliability, vol.39, pp.784-88, 1982.
« The Scale for the Assessment of Negative Symptoms (SANS) ». The British Journal of Psychiatry, vol.155, pp.49-52, 1989. ,
« Investigation of the role of the jumping-to-conclusions bias for short-term functional outcome in schizophrenia, Psychiatry Research, vol.218, pp.341-388, 2014. ,
, « schizophrenia.pdf Guidelines, 2004.
« schizophrenia-watch.pdf Guidelines », 2009. ,
, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5®). Arlington: American Psychiatric Association, 2013.
Randomized Trial of a Single Dose of Placebo, Haloperidol, and Risperidone in Healthy Volunteers, Negative Signs and Symptoms Secondary to Antipsychotics: A Double-Blind, vol.163, pp.488-93, 2006. ,
Subjective Tolerability of Antipsychotic Medications and the Emerging Science of Subjective Tolerability Disorders, Expert Review of Pharmacoeconomics & Outcomes Research, vol.10, issue.1, pp.1-4, 2010. ,
« The Use of Acceptance and Commitment Therapy to Prevent the Rehospitalization of Psychotic Patients: A Randomized Controlled Trial, Journal of Consulting and Clinical Psychology, vol.70, issue.5, pp.1129-1168, 2002. ,
Die Wirksamkeit individualisierter Kognitiver Verhaltens therapie bei schizophrener Negativsymptomatik und sozialer Behinderung: Eine kontrollierte Studie, Zeitschrift für Klinische Psychologie und Psychotherapie, vol.30, issue.4, pp.268-278, 2001. ,
Cognitive Therapy and the Emotional Disorders, 1976. ,
, Cognitive Approaches to Schizophrenia: Theory and Therapy, vol.1, pp.577-606, 2005.
Cognitive Therapy of Depression, 1979. ,
« Explaining Delusions: A Cognitive Perspective », Trends in Cognitive Sciences, vol.10, issue.5, pp.219-245, 2006. ,
« Persecutory Delusions: A Review and Theoretical Integration », Clinical Psychology Review, vol.21, issue.8, pp.1143-92, 2001. ,
« Social skills training with schizophrenics: A meta-analytic evaluation, Journal of Consulting and Clinical Psychology, vol.58, issue.6, pp.741-788, 1990. ,
, The Structure of Negative Symptoms Within Schizophrenia: Implications for Assessment, vol.32, pp.238-283, 2006.
« Toward the next Generation of Negative Symptom Assessments: The Collaboration to Advance Negative Symptom Assessment in Schizophrenia, Schizophrenia Bulletin, vol.37, issue.2, pp.291-99, 2011. ,
Dementia praecox, oder Gruppe der, 1911. ,
« Deficit States in Schizophrenia and Their Association with the Length of Illness and Gender, European Archives of Psychiatry and Clinical Neuroscience, vol.251, issue.6, pp.272-78, 2001. ,
« Predicting Quality of Life from Symptomatology in Schizophrenia at Exacerbation and Stabilization », Psychiatry Research, vol.86, issue.2, pp.131-173, 1999. ,
« Hallucinatory Experiences in Extreme-Altitude Climbers, Neuropsychology, and Behavioral Neurology, vol.12, issue.1, pp.67-71, 1999. ,
Theory of Mind" in Schizophrenia: A Review of the Literature », Schizophrenia Bulletin, vol.31, issue.1, pp.21-42, 2005. ,
« Examining Transcranial Direct-Current Stimulation (TDCS) as a Treatment for Hallucinations in Schizophrenia, The American Journal of Psychiatry, vol.169, issue.7, pp.719-743, 2012. ,
« Positive and Negative Symptom Response to Clozapine in Schizophrenic Patients with and without the Deficit Syndrome, The American Journal of Psychiatry, vol.155, issue.6, pp.751-60, 1998. ,
The Feeling Good Handbook, 2000. ,
« Defeatist Performance Beliefs, Negative Symptoms, and Functional Outcome in Schizophrenia: A Meta-Analytic Review », Schizophrenia Bulletin, vol.42, issue.6, pp.1343-52, 2016. ,
, Treatment of Negative Symptoms, vol.11, pp.440-52, 1985.
« Deficit and Nondeficit Forms of Schizophrenia: The Concept, The American Journal of Psychiatry, vol.145, issue.5, pp.578-83, 1988. ,
« Poor Savouring and Low Self-Efficacy Are Predictors of Anhedonia in Patients with Schizophrenia Spectrum Disorders, Psychiatry Research, vol.210, issue.3, pp.830-864, 2013. ,
, Cognitive Remediation for Negative Symptoms of Schizophrenia: A Network Meta-Analysis », vol.52, pp.43-51, 2017.
« Mindfulness Groups for People with Psychosis, Behavioural and Cognitive Psychotherapy, vol.33, issue.3, pp.351-59, 2005. ,
« Safety-Seeking Behaviours and Verbal Auditory Hallucinations in Schizophrenia », Psychiatry Research, vol.220, issue.1-2, pp.158-62, 2014. ,
, Cognitive behaviour therapy for schizophrenia, 2002.
« Social Skills Training in Adult Psychiatric Populations: A Meta-Analysis », Journal of Behavior Therapy and Experimental Psychiatry, vol.22, issue.3, pp.203-213, 1991. ,
, Les psychothérapies cognitives et comportementales. 6e édition, 2017.
« Negative Expectancy Appraisals and Defeatist Performance Beliefs and Negative Symptoms of Schizophrenia, Psychiatry Research, vol.189, issue.1, pp.43-48, 2001. ,
, , 2012.
« Efficacy of Second-Generation-Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia: A Meta-Analysis of Randomized Clinical Trials, Revista De Psiquiatria Y Salud Mental, vol.4, issue.3, pp.126-169, 2011. ,
Behavioral Psychotherapy for Schizophrenia: A Review of Recent Empirical Studies, Schizophrenia Research, vol.43, issue.2-3, pp.71-90, 2000. ,
« Social Functioning and Neurocognitive Deficits in Outpatients with Schizophrenia: A 2-Year Follow-Up », Schizophrenia Research, vol.37, issue.1, pp.13-20, 1999. ,
« Repetitive Transcranial Magnetic Stimulation for Negative Symptoms of Schizophrenia: Review and Meta-Analysis, The Journal of Clinical Psychiatry, vol.71, issue.4, pp.411-429, 2010. ,
« The Evolution of Insight, Paranoia and Depression during Early Schizophrenia, Psychological Medicine, vol.34, issue.2, pp.285-92, 2004. ,
, Management of Negative Symptoms among Patients with Schizophrenia Attending Multiple-Family Groups, vol.51, pp.513-532, 2000.
, Psychosocial Treatments for Negative Symptoms in Schizophrenia: Current Practices and Future Directions, vol.33, pp.914-942, 2013.
« The Influence of Metacognitive Training on Delusion Severity and Metacognitive Ability in Schizophrenia, Journal of Psychiatric and Mental Health Nursing, vol.21, issue.9, pp.841-888, 2014. ,
, Treatment of Schizophrenia Negative Symptoms: Future Prospects, vol.32, pp.234-271, 2006.
Burden of Care: The Impact of Functional Psychiatric Illness on the Patient's Family », The British Journal of Psychiatry: The Journal of Mental Science, vol.150, pp.285-92, 1987. ,
Sustained Antipsychotic Effect of Metacognitive Training in Psychosis: A Randomized-Controlled Study, European Psychiatry: The Journal of the Association of European Psychiatrists, vol.29, issue.5, pp.275-81, 2014. ,
Se rétablir de la schizophrénie: Guide pratique pour les professionnels. 2e édition, 2015. ,
Pleasure Skills Training: A New Intervention to Reduce Anhedonia in Schizophrenia », Perspectives in Psychiatric Care, vol.46, issue.3, pp.171-81, 2010. ,
« Positive Emotions Program for Schizophrenia (PEPS): A Pilot Intervention to Reduce Anhedonia and Apathy, BMC Psychiatry, vol.15, p.231, 2015. ,
, Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, vol.40, issue.6, pp.1539-1587, 2015.
Analysis of Cognitive Deficits in Adults with a Diagnosis of Schizophrenia, Neuropsychology Review, vol.15, issue.2, pp.73-95, 2015. ,
« Metacognition and cognitive monitoring: A new area of cognitive-developmental inquiry, American Psychologist, vol.34, issue.10, pp.906-917, 1979. ,
« The London-East Anglia Randomized Controlled Trial of Cognitive-Behaviour Therapy for Psychosis. IV: Self-Esteem and Persecutory Delusions, The British Journal of Clinical Psychology, vol.37, pp.415-445, 1998. ,
Analysis of the Effects of Repetitive Transcranial Magnetic Stimulation (RTMS) on Negative and Positive Symptoms in Schizophrenia, Schizophrenia Research, vol.108, issue.1-3, pp.11-24, 2009. ,
, Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials, vol.41, pp.892-99, 2015.
, Anhedonia in Schizophrenia: Distinctions between Anticipatory and Consummatory Pleasure, vol.93, pp.253-60, 2007.
Référentiel de psychiatrie : Psychiatrie de l'adulte. Psychiatrie de l'enfant et de l'adolescent. Addictologie. 1re édition. Rennes; Tours: Presses universitaire François Rabelais, 2014. ,
, Left Dorsolateral Prefrontal Cortex Anodal TDCS Effects on Negative Symptoms in Schizophrenia, vol.8, pp.989-91, 2015.
« Distressing Behaviour of Schizophrenics at Home, Acta Psychiatrica Scandinavica, vol.86, issue.3, pp.185-88, 1992. ,
Therapy for Psychosis in Schizophrenia: An Effect Size Analysis, Schizophrenia Research, vol.48, issue.2-3, pp.335-377, 2001. ,
« Defeatist Beliefs as a Mediator of Cognitive Impairment, Negative Symptoms, and Functioning in Schizophrenia, Schizophrenia Bulletin, vol.35, issue.4, pp.798-806, 2009. ,
« Six-Month Follow-Up of Recovery-Oriented Cognitive Therapy for Low-Functioning Individuals With Schizophrenia, Psychiatric Services, vol.68, issue.10, pp.997-1002, 2017. ,
« Randomized Trial to Evaluate the Efficacy of Cognitive Therapy for Low-Functioning Patients with Schizophrenia, Archives of General Psychiatry, vol.69, issue.2, pp.121-148, 2012. ,
« Successfully Breaking a 20-Year Cycle of Hospitalizations with Recovery-Oriented Cognitive Therapy for Schizophrenia, Psychological Services, vol.11, issue.2, pp.125-158, 2014. ,
Effects of Solitary Confinement, The American Journal of Psychiatry, vol.140, issue.11, pp.1450-54, 1983. ,
, Lithium in Chronic Schizophrenia, vol.136, pp.454-55, 1979.
, , 2012.
« Onset and Early Course as Determinants of the Further Course of Schizophrenia », Acta Psychiatrica Scandinavica. Supplementum, pp.44-48, 2000. ,
, Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie, vol.42, issue.2, pp.139-51, 1997.
« The Course of Schizophrenia in the Light of Modern Follow-up Studies: The ABC and WHO Studies ». European Archives of Psychiatry and Clinical Neuroscience, vol.249, pp.14-26, 1999. ,
, « Définition / classification des handicaps (CIH et OMS), Handicap.fr, 2013.
, Guide ALD23 Schizophrénie, 2007.
« Alpha-2 Receptor Antagonist Add-on Therapy in the Treatment of Schizophrenia; a Meta-Analysis », Schizophrenia Research, vol.134, issue.2-3, pp.202-208, 2012. ,
« Neurocognitive deficit in schizophrenia: A quantitative review of the evidence », Neuropsychology, vol.12, issue.3, pp.426-471, 1998. ,
, Hypofrontality in Schizophrenia: A Meta-Analysis of Functional Imaging Studies, vol.110, pp.243-56, 2004.
« Two-Year Outcome in First-Episode Schizophrenia: Predictive Value of Symptoms for Quality of Life, The American Journal of Psychiatry, vol.155, issue.9, pp.1196-1201, 1998. ,
« Schizophrenic Patients without Neuropsychological Deficits: Subgroup, Disease Severity or Cognitive Compensation?, Psychiatry Research, vol.112, issue.1, pp.1-11, 2002. ,
, Psychothérapies : Trois approches évaluées, 2004.
, , 2014.
« Cognitive-Behavioural Therapy for the Symptoms of Schizophrenia: Systematic Review and Meta-Analysis with Examination of Potential Bias, The British Journal of Psychiatry: The Journal of Mental Science, vol.204, issue.1, pp.20-29, 2014. ,
, The Israel Journal of Psychiatry and Related Sciences, vol.47, issue.1, pp.4-16, 2010.
« Battling boredom : Group cognitive behaviour therapy for negative symptoms of schizophrenia, Behavioural and Cognitive Psychotherapy, vol.30, issue.3, pp.341-387, 2002. ,
« A pilot study of loving-kindness meditation for the negative symptoms of schizophrenia, Schizophrenia Research, vol.129, issue.2, pp.137-177, 2011. ,
« N-Methyl-d-Aspartate (NMDA) Receptor Dysfunction or Dysregulation: The Final Common Pathway on the Road to Schizophrenia?, Brain Research Bulletin, vol.83, issue.3-4, pp.108-129, 2010. ,
, The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, vol.13, pp.261-76, 1987.
« Empirical Validation of Primary Negative Symptoms: Independence from Effects of Medication and Psychosis, The American Journal of Psychiatry, vol.156, issue.3, pp.406-417, 1999. ,
,
, Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms », Journal of Clinical Psychopharmacology, vol.35, issue.4, pp.374-81, 2015.
Michael's Game," a Card Game for the Treatment of Psychotic Symptoms, Patient Education and Counseling, vol.83, issue.2, pp.210-226, 2011. ,
, Mindfulness Interventions for Psychosis: A Meta-Analysis, vol.150, pp.176-84, 2013.
« Causal Attributions in Paranoia and Depression: Internal, Personal, and Situational Attributions for Negative Events, Journal of Abnormal Psychology, vol.106, issue.2, pp.341-386, 1997. ,
Thérapie cognitive de la schizophrénie, 2011. ,
« A Separate Disease within the Syndrome of Schizophrenia, Archives of General Psychiatry, vol.58, issue.2, pp.165-71, 2001. ,
, The NIMH-MATRICS Consensus Statement on Negative Symptoms, vol.32, pp.214-233, 2006.
, The Brief Negative Symptom Scale: Psychometric Properties, vol.37, pp.300-305, 2011.
Analysis of Noradrenergic and Specific Serotonergic Antidepressant Use in Schizophrenia, The International Journal of Neuropsychopharmacology, vol.17, issue.2, pp.343-54, 2014. ,
, Anhedonia and Affect Deficit States, 1987.
, Adverse Effects of Cognitive Behavioral Therapy and Cognitive Remediation in Schizophrenia: Results of the Treatment of Negative Symptoms Study, vol.200, pp.569-76, 2012.
, Cognitive Behavioural Treatment of Negative Symptoms in Schizophrenia Patients: Study Design of the TONES Study, Feasibility and Safety of Treatment, vol.259, pp.149-154, 2009.
« Negative Symptoms of Schizophrenia as Primary Target of Cognitive Behavioral Therapy: Results of the Randomized Clinical TONES Study, Schizophrenia Bulletin, vol.37, issue.2, pp.98-110, 2011. ,
« A standardized psychiatric assessment scale for rating chronic psychotic patients, Acta Psychiatrica Scandinavica, vol.55, issue.4, pp.299-308, 1977. ,
« The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation, The American Journal of Psychiatry, vol.170, issue.2, pp.165-72, 2013. ,
, Targeting Negative Symptoms in Schizophrenia: Results from a Proof-of-Concept Trial Assessing Prefrontal Anodic TDCS Protocol, vol.166, pp.362-63, 2015.
« Etude des propriétés psychométriques de la PANSS dans sa version française dans une population de patients schizophrènes-Psychometrics properties of the PANSS in a sample of French schizophrenic patients, vol.23, pp.1-9, 1997. ,
« Fiche descriptive et traduction française de la SANS, Psychiatrie & Psychobiologie, vol.2, issue.6, pp.414-438, 1987. ,
The Emotional Brain, 1998. ,
Code de l'action sociale et des familles. LOI n° 2005-102 du 11 février 2005 pour l'égalité des droits et des chances, la participation et la citoyenneté des personnes handicapées, pp.2005-102 ,
« Second-Generation versus First-Generation Antipsychotic Drugs for Schizophrenia: A Meta-Analysis », Lancet, vol.373, issue.9657, pp.31-41, 2009. ,
Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia, The American Journal of Psychiatry, vol.166, issue.2, pp.152-63, 2009. ,
« How Effective Are Second-Generation Antipsychotic Drugs? A Meta-Analysis of Placebo-Controlled Trials, Molecular Psychiatry, vol.14, issue.4, pp.429-476, 2009. ,
Antipsychotic: A Meta-Analysis of Randomized Controlled Trials, The American Journal of Psychiatry, vol.159, issue.2, pp.180-90, 2002. ,
« Assessment of negative and positive symptoms in schizophrenia, Schizophrenia bulletin, vol.9, issue.3, pp.368-76, 1983. ,
« The Subjective Experience of Deficits in Schizophrenia, Comprehensive Psychiatry, vol.29, issue.2, pp.157-64, 1988. ,
Genetic Risk and Outcome of Psychosis (GROUP) Investigators. « Two Subdomains of Negative Symptoms in Psychotic Disorders: Established and Confirmed in Two Large Cohorts, Journal of Psychiatric Research, vol.47, issue.6, pp.718-743, 2013. ,
, Minocycline Supplementation for Treatment of Negative Symptoms in Early-Phase Schizophrenia: A Double Blind, Randomized, Controlled Trial, vol.153, pp.169-76, 2014.
« Manual for the expanded brief psychiatric rating scale ». Schizophrenia bulletin, vol.12, pp.594-602, 1986. ,
« Marathon Volleyball: Changes after 61 Hours Play, » British Journal of Sports Medicine, vol.19, issue.4, pp.228-257, 1985. ,
, Methodological Aspects of Onset Assessment in Schizophrenia ». Schizophrenia Research, vol.15, issue.3, pp.265-76, 1995.
,
, Cognitive Remediation in Schizophrenia, The American Journal of Psychiatry, vol.164, issue.12, pp.1791-1802, 2007.
« Symptômes négatifs de la schizophrénie : de l'électrophysiologie à l'électrothérapie, L'Encéphale, vol.41, issue.6, pp.50-56, 2015. ,
Neurophysiologie clinique en psychiatrie, pp.133-164, 2015. ,
« Predictive Values of Neurocognition and Negative Symptoms on Functional Outcome in Schizophrenia: A Longitudinal First-Episode Study with 7-Year Follow-Up, The American Journal of Psychiatry, vol.162, issue.3, pp.495-506, 2005. ,
L'entretien en thérapie comportementale et cognitive. 3ème éd, 2011. ,
« Clinical Evaluation of Negative Symptoms in Schizophrenia, European Psychiatry: The Journal of the Association of European Psychiatrists, vol.22, issue.6, pp.380-86, 2007. ,
« Pharmacological Treatment of Negative Symptoms in Schizophrenia ». European Archives of Psychiatry and Clinical Neuroscience, vol.265, pp.567-78, 2015. ,
« Effects of Fronto-Temporal Transcranial Direct Current Stimulation on Auditory Verbal Hallucinations and Resting-State Functional Connectivity of the Left Temporo-Parietal Junction in Patients With Schizophrenia, Schizophrenia Bulletin, vol.42, issue.2, pp.318-344, 2016. ,
« Sustained and "Sleeper" Effects of Group Metacognitive Training for Schizophrenia: A Randomized Clinical Trial, JAMA Psychiatry, vol.71, issue.10, pp.1103-1114, 2014. ,
« The Contribution of Metamemory Deficits to Schizophrenia », Journal of Abnormal Psychology, vol.115, issue.1, pp.15-25, 2006. ,
« A Generalized Bias against Disconfirmatory Evidence in Schizophrenia, Psychiatry Research, vol.142, issue.2-3, pp.157-65, 2006. ,
« Investigation of Metamemory Dysfunctions in First-Episode Schizophrenia, Schizophrenia Research, vol.81, issue.2-3, pp.247-52, 2006. ,
Entraînement des habiletés métacognitives pour les personnes atteintes de schizophrénie (EMC), 2007. ,
,
, « Validation de la version française de l'échelle abrégée d'appréciation psychiatrique étendue avec ancrage, BPRS-E(A) ». Encéphale, vol.36, issue.4, pp.294-301, 2010.
, « full-guideline-pdf-490503565, 2014.
, « Psychosis and schizophrenia in adults prevention and management, 2014.
, Psychosis and Schizophrenia in Adults | Guidance and Guidelines | NICE, 2015.
« Psychological Well-Being in Families with a Member Suffering from Schizophrenia. An Investigation into Long-Standing Problems, The British Journal of Psychiatry: The Journal of Mental Science, vol.161, pp.249-51, 1992. ,
Myin-Germeys I. « Emotional Experience in Negative Symptoms of Schizophrenia-No Evidence for a Generalized Hedonic Deficit, Schizophrenia Bulletin, vol.39, issue.1, pp.217-242, 2013. ,
« Efficacy and Tolerability of Minocycline Augmentation Therapy in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Human Psychopharmacology, vol.29, issue.5, pp.483-91, 2014. ,
, Supportive Therapy for Schizophrenia: Possible Mechanisms and Implications for Adjunctive Psychosocial Treatments, vol.30, pp.101-113, 2004.
, Cognitive Behavioral Therapy of Negative Symptoms, vol.65, pp.815-845, 2009.
, Delusions: A Longitudinal Analysis, vol.44, pp.481-514, 2006.
, Efficiency of Transcranial Electrostimulation on Anxiety and Insomnia Symptoms during a Washout Period in Depressed Patients. A Double-Blind Study, vol.29, pp.451-56, 1991.
« Psychological Treatments in Schizophrenia: I. Meta-Analysis of Family Intervention and Cognitive Behaviour Therapy, Psychological Medicine, vol.32, issue.5, pp.763-82, 2002. ,
« Negative symptoms in schizophrenia: their longitudinal course and prognostic importance, Schizophrenia Bulletin, vol.11, issue.3, pp.427-466, 1985. ,
Cognitive Behavioral Therapy for Social Activation in Recent-Onset Psychosis: Randomized Controlled Trial, Journal of Consulting and Clinical Psychology, vol.87, issue.2, pp.151-160, 2019. ,
« Positive and Negative Symptom Behaviors and Caregiver Burden in the Relatives of Persons with Schizophrenia, Schizophrenia Research, vol.26, issue.1, pp.71-80, 1997. ,
« Altérations cognitives et plaintes mnésiques lors d'un traitement par électroconvulsivothérapie : revue de la littérature ». Annales médicopsychologique, vol.171, pp.285-294, 2013. ,
« Social Burden of Positive and Negative Schizophrenia, International Journal of Social Psychiatry, vol.37, issue.4, pp.242-50, 1991. ,
« Cognitive Behavioral Therapy for Schizophrenia: An Empirical Review, The Journal of Nervous and Mental Disease, vol.189, issue.5, pp.278-87, 2001. ,
, Dysfunctional Attitudes and Symptom Expression in Schizophrenia: Differential Associations With Paranoid Delusions and Negative Symptoms, vol.18, pp.163-73, 2004.
, The Negative Symptoms of Schizophrenia: A Cognitive Perspective, vol.50, pp.247-57, 2005.
« Cognitive Therapy for Schizophrenia: A Preliminary Randomized Controlled Trial, Schizophrenia Research, vol.63, issue.1-2, pp.1-11, 2003. ,
« Exploratory RCT of Art Therapy as an adjunctive treatment in schizophrenia », Journal of Mental Health, vol.16, issue.4, pp.483-91, 2009. ,
« Quality of life and psychopathology during the course of schizophrenia, Comprehensive Psychiatry, vol.50, issue.6, pp.542-590, 2009. ,
« Male Gender Is Associated with Deficit Schizophrenia: A Meta-Analysis », Schizophrenia Research, vol.47, issue.2-3, pp.141-188, 2001. ,
Interpersonal Process in Cognitive Therapy ,
, Cognitive Model and Cognitive Behavior Therapy for Schizophrenia: An Overview, vol.68, pp.145-53, 2014.
« Cognitive Behavior Therapy for Schizophrenia: A Meta-Analytical Review of Randomized Controlled Trials, Nordic Journal of Psychiatry, vol.65, issue.3, pp.162-74, 2011. ,
« Getting Formal with Dopamine and Reward », Neuron, vol.36, issue.2, pp.241-63, 2002. ,
, Discrepancy between Subjective and Objective Ratings for Negative Symptoms, vol.34, pp.11-13, 2000.
« The Subjective Experience of Negative Symptoms: A self-rating scale, Comprehensive Psychiatry, vol.34, issue.3, pp.192-97, 1993. ,
« A Randomized Controlled Trial of Cognitive-Behavioral Therapy for Persistent Symptoms in Schizophrenia Resistant to Medication, Archives of General Psychiatry, vol.57, issue.2, pp.165-72, 2000. ,
, Revisiting the Therapeutic Effect of RTMS on Negative Symptoms in Schizophrenia: A Meta-Analysis », vol.215, pp.505-518, 2014.
, Efficacy of Antidepressants in Treating the Negative Symptoms of Chronic Schizophrenia: Meta-Analysis, vol.197, pp.174-79, 2010.
« Sensory Deprivation and Clinical Psychiatry, British Journal of Hospital Medicine, vol.32, issue.5, pp.256-60, 1984. ,
, Controlled Study of Lithium Combined with Neuroleptics in Chronic Schizophrenic Patients, vol.132, pp.1315-1332, 1975.
,
, « Jumping to Conclusions, a Lack of Belief Flexibility and Delusional Conviction in Psychosis: A Longitudinal Investigation of the Structure, Frequency, and Relatedness of Reasoning Biases, vol.121, pp.129-168, 2012.
« Negative Symptoms of Schizophrenia: A Problem That Will Not Go Away, Acta Psychiatrica Scandinavica, vol.115, issue.1, pp.4-11, 2007. ,
, Cognitive Behavioral Therapy for Negative Symptoms (CBT-n) in Psychotic Disorders: A Pilot Study, vol.44, pp.300-306, 2013.
, Cognitieve therapie voor demoralisatie bij schizofrenie, vol.43, p.205, 2010.
Wales Randomized Controlled Trial of Cognitive Behaviour Therapy for Acute Schizophrenia Spectrum Disorders: Outcomes at 6 and 12 ,
, Psychological Medicine, vol.34, issue.3, pp.413-435, 2004.
, Psychotic Symptoms as a Continuum between Normality and Pathology, vol.54, pp.140-51, 2009.
« Repetitive Transcranial Magnetic Stimulation of the Human Prefrontal Cortex Induces Dopamine Release in the Caudate Nucleus, The Journal of Neuroscience, vol.21, issue.15, p.157, 2001. ,
, Mindfulness in Schizophrenia: Associations with Self-Reported Motivation, Emotion Regulation, Dysfunctional Attitudes, and Negative Symptoms, vol.168, pp.537-579, 2015.
, Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia, vol.18, 2015.
« The Efficacy of Lamotrigine in Clozapine-Resistant Schizophrenia: A Systematic Review and Meta-Analysis », Schizophrenia Research, vol.109, issue.1-3, pp.10-14, 2009. ,
, Therapy for Command Hallucinations: Randomised Controlled Trial, vol.184, pp.312-332, 2004.
Drugs for Schizophrenia ». The Cochrane Database of Systematic Reviews, 2006. ,
, Cognitive Behavior Therapy for Schizophrenia, vol.163, pp.365-73, 2006.
« Outcomes of an Effectiveness Trial of Cognitive-Behavioural Intervention by Mental Health Nurses in Schizophrenia, The British Journal of Psychiatry: The Journal of Mental Science, vol.189, issue.1, pp.36-40, 2006. ,
« A Randomized Controlled Trial of Cognitive-Behavior Therapy for Persistent Symptoms in Schizophrenia: A Five-Year Follow-Up », Schizophrenia Research, vol.98, issue.1-3, pp.1-7, 2008. ,
« The Additional Therapeutic Effect of Group Music Therapy for Schizophrenic Patients: A Randomized Study, Acta Psychiatrica Scandinavica, vol.116, issue.5, pp.362-70, 2007. ,
Patterns of interactions in families of schizophrenics, Die andere Seite der Schizophrenie : Patienten zu Hause, 1977. ,
, Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis, vol.47, pp.185-94, 2014.
, Memantine Augmentation in Clozapine-Refractory Schizophrenia: A Randomized, Double-Blind, vol.46, pp.1909-1930, 2016.
, Negative Symptoms in Schizophrenia: The Importance of Identification and Treatment, vol.25, 2008.
, Adapted Cognitive-Behavioural Therapy Required for Targeting Negative Symptoms in Schizophrenia: Meta-Analysis and Meta-Regression, vol.45, pp.453-65, 2015.
Psychotic symptoms in non-clinical populations and the continuum of psychosis, Schizophrenia Research, vol.54, issue.1, pp.59-65, 2002. ,
Analysis of Efficacy of Mirtazapine as an Adjunctive Treatment of Negative Symptoms in Schizophrenia, Clinical Schizophrenia & Related Psychoses, vol.9, issue.2, pp.88-95, 2015. ,
Thérapie cognitive basée sur le concept de rétablissement pour la schizophrénie : un cas clinique », Journal de Thérapie Comportementale et Cognitive, vol.29, issue.2, pp.57-66, 2018. ,
« Evidence of Clozapine's Effectiveness in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Trials, The American Journal of Psychiatry, vol.156, issue.7, pp.990-99, 1999. ,
« Paradoxical Effects of Thought Suppression, Journal of Personality and Social Psychology, vol.53, issue.1, pp.5-13, 1987. ,
, Genève: Organisation Mondiale de la Santé, WHO. Classification internationale du fonctionnement, du handicap et de la santé: CIF. éd, 2001.
, Treatment Acceptance and Therapeutic Relationship in the Early Stage of Cognitive Behavioral Therapy on Negative Symptoms of Schizophrenia, vol.27, pp.1007-1013, 2008.
Psychosoziale Interventionen Bei Schizophrenen Patienten Wirksam?, Eine Metaanalyse ». Verhaltenstherapie, vol.6, issue.1, pp.4-13, 1996. ,
, Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes, vol.168, pp.472-85, 2011.
, Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, vol.34, pp.523-560, 2008.